Is "prices start from $87" honest?

Yes, and that is worth stating because it is the exception rather than the rule here. Mondae's semaglutide page charges $87 per month on the one-month plan — the same figure as the headline — and $75 on the three-month plan. Compare that with SexyMD, whose "as low as $199/mo" is a 48-week commitment against a $269 month-to-month rate, or Collective, whose "$59" excludes a mandatory $199 annual membership. Mondae is one of four providers in this batch whose headline survives its own checkout.

Does the price go up as my dose increases?

No. Each product page states that the price is the same at every dose, so titrating from a starting dose to a maintenance dose does not change the bill. That is a more consequential feature than the headline number, because dose-scaled pricing is the mechanism by which several providers turn an attractive first month into a much more expensive year. Collective and Pallas Health make the same flat-dose commitment; a number of providers on this board do not.

Does Mondae say where its medication is compounded?

More specifically than most. Rather than a single reference to a partner pharmacy, each product page names the compounding source for that item and states the additive explicitly — noting, for instance, where a preparation contains no additive. That is genuinely unusual at this price point, where the norm is a generic "licensed US compounding pharmacy" line. It stops short of publishing a full address and 503A/503B designation, which Clume Health and Nex Gen Health Rx do.

Which states does Mondae serve?

It does not publish a list, and we could not find one on any page. That is the main gap in an otherwise well-disclosed service. Compounded GLP-1 availability genuinely varies with state telehealth and compounding rules, so if you are in a state with tighter requirements, confirm during the questionnaire. Andrew Meds states 44 states specifically, which is the more careful way to publish this.

Is the NAD+ worth $129 a month?

That is a question about evidence rather than price, and the honest answer is that injected NAD+ has no controlled human outcome trials behind it. The randomized data in this area sits with the oral precursors, nicotinamide riboside and NMN, and even there the endpoint reached is a raised blood NAD+ level rather than a demonstrated clinical benefit. Mondae's $129 month-to-month and $93 three-month rates are competitive against this board — Bayan is $99, Nex Gen $299 — but price is the only dimension on which the comparison is meaningful.

Mondae is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: Semaglutide $87/mo month-to-month or $75 on 3 months; tirzepatide $126 and $124. Flat at every dose. It is cash-pay and states it does not bill insurance. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. What our record does not establish: which states it serves. Ask for those in writing before you pay.

Is Mondae expensive compared with other GLP-1 telehealth providers?

Mondae publishes a starting figure of $87/mo. Across the 42 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $269 with a median of $179, which puts Mondae below the median, toward the cheaper end. The other 31 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Updated September 2026

Mondae review

Headline matches checkout

Advertises "from $87" and then charges $87 — one of only four providers in this batch whose headline survives its own checkout.

Our verdict

Mondae is the cleanest low-cost option in this batch. It advertises "prices start from $87" and its semaglutide page charges exactly $87 month-to-month, dropping to $75 on a three-month plan — no prepay dressed up as monthly, no membership stacked underneath, no dose-scaled increase. It goes further than almost anyone at this price by naming the compounding source per product rather than referring to an unnamed partner pharmacy, and its LegitScript seal resolves. The longevity line is priced in the same honest shape: sermorelin $99, NAD+ $129 month-to-month or $93 on three months, glutathione $99 or $63. What it does not publish is a list of states or an operating company, and the menu is narrow. But on the single question this category most often fails — does the advertised price survive contact with the checkout — Mondae passes.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →Semaglutide $87/mo month-to-month or $75 on 3 months; tirzepatide $126 and $124. Flat at every dose

At a glance

Category: GLP-1 telehealth
Access: Semaglutide $87/mo month-to-month or $75 on 3 months; tirzepatide $126 and $124. Flat at every dose
Medications: Compounded semaglutide · Compounded tirzepatide
Insurance: Cash-pay, no insurance
Visit: Quiz intake / Async intake
Availability: Not published
LegitScript: Claimed by provider
Updated: September 2026

What it is

A telehealth service selling compounded semaglutide and tirzepatide for weight loss alongside an anti-aging line of sermorelin, NAD+ and glutathione injections, all on flat monthly or three-month plans with the price held constant at every dose. It claims more than 40,000 patients and carries a LegitScript certification whose seal id (45602869) resolves against the issuer.

How it works

Asynchronous and questionnaire-led, referenced eleven times across the site, with 1:1 provider guidance described as continuing through treatment. The distinguishing disclosure is per-product sourcing: rather than a single line about a partner pharmacy, each product page names the compounding source and states the additive explicitly — the semaglutide, NAD+ and glutathione pages each identify the preparation and note where additives are or are not present. No list of states served and no operating company are published, which are the two gaps against otherwise strong disclosure.

Pricing transparency

Honest and simple. Compounded semaglutide is $87/month on the one-month plan and $75/month on the three-month plan; compounded tirzepatide is $126 and $124. Sermorelin injection is $99 billed monthly; NAD+ injection $129 on one month or $93 on three; glutathione injection $99 on one month or $63 on three. The site's headline — "prices start from $87" — is the genuine month-to-month semaglutide rate rather than a prepay average, which puts Mondae in a small group here alongside Andrew Meds, Bayan Health and Nova. Every product page states that the price is the same at every dose, so titration does not raise the bill.

Branded vs compounded

Compounded semaglutide and tirzepatide, plus sermorelin, NAD+ and glutathione injections. Product pages name the compounding source and state whether additives are present, which is unusually specific for this price point. On the evidence: the semaglutide and tirzepatide trial data is strong and belongs to the branded products rather than to compounded copies, which the FDA does not assess for potency, purity or consistency; sermorelin has a genuine growth-hormone-axis mechanism with thin long-term outcome data; injected NAD+ has no controlled human outcome trials, and the randomized evidence sits with oral NR and NMN precursors on the modest endpoint of raising blood NAD+; and injected glutathione has essentially no controlled human outcome data for the uses it is marketed on.

Pros and watch-outs

What we like

The advertised "from $87" is the real month-to-month price, not a prepay average
Price held constant at every dose, stated on each product page
Names the compounding source per product rather than referring to an unnamed pharmacy
LegitScript seal id resolves against the issuer
Longevity line priced in the same clean shape — sermorelin $99, NAD+ $129/$93, glutathione $99/$63
No membership fee stacked underneath the medication price

Watch-outs

No list of states served published anywhere
The operating company is not named
Narrow menu — no testosterone, ED or broader peptide line
The 40,000-patient claim is not verifiable from the site

Best for

Buyers who want a low, genuinely month-to-month GLP-1 price with the compounding source named, and no membership underneath it.

Who should look elsewhere

Readers wanting a deep peptide catalog, hormones or sexual health from one provider, or who need confirmation of state availability up front.

The evidence behind what Mondae prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
Tirzepatide vs semaglutide for weight loss: what the trials actually support
Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.
Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.
Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How Mondae compares

A few alternatives worth a look, depending on what you’re optimizing for.

Andrew Meds
Anyone who wants the prepay ladder and its true monthly cost published on one page
See Andrew Meds →
Bayan Health
Readers who want a microdose entry point and their lab work priced in the same catalog
See Bayan Health →
Magnolia Regenerative Medicine
A low-cost GLP-1 bought alongside a deep, cheap peptide and hormone menu
See Magnolia Regenerative Medicine →

Compare all providers side by side →

More GLP-1 telehealth reviews: yourEraBreeze MedsBodybuilding Health+Synergy RxGala HealthDirect Meds

Nadia Feldman

Access & cost · Reviewed and last verified September 2026

How we assessed this. This review reflects Aminoscope’s own read of Mondae’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

Is "prices start from $87" honest?: Yes, and that is worth stating because it is the exception rather than the rule here. Mondae's semaglutide page charges $87 per month on the one-month plan — the same figure as the headline — and $75 on the three-month plan. Compare that with SexyMD, whose "as low as $199/mo" is a 48-week commitment against a $269 month-to-month rate, or Collective, whose "$59" excludes a mandatory $199 annual membership. Mondae is one of four providers in this batch whose headline survives its own checkout.
Does the price go up as my dose increases?: No. Each product page states that the price is the same at every dose, so titrating from a starting dose to a maintenance dose does not change the bill. That is a more consequential feature than the headline number, because dose-scaled pricing is the mechanism by which several providers turn an attractive first month into a much more expensive year. Collective and Pallas Health make the same flat-dose commitment; a number of providers on this board do not.
Does Mondae say where its medication is compounded?: More specifically than most. Rather than a single reference to a partner pharmacy, each product page names the compounding source for that item and states the additive explicitly — noting, for instance, where a preparation contains no additive. That is genuinely unusual at this price point, where the norm is a generic "licensed US compounding pharmacy" line. It stops short of publishing a full address and 503A/503B designation, which Clume Health and Nex Gen Health Rx do.
Which states does Mondae serve?: It does not publish a list, and we could not find one on any page. That is the main gap in an otherwise well-disclosed service. Compounded GLP-1 availability genuinely varies with state telehealth and compounding rules, so if you are in a state with tighter requirements, confirm during the questionnaire. Andrew Meds states 44 states specifically, which is the more careful way to publish this.
Is the NAD+ worth $129 a month?: That is a question about evidence rather than price, and the honest answer is that injected NAD+ has no controlled human outcome trials behind it. The randomized data in this area sits with the oral precursors, nicotinamide riboside and NMN, and even there the endpoint reached is a raised blood NAD+ level rather than a demonstrated clinical benefit. Mondae's $129 month-to-month and $93 three-month rates are competitive against this board — Bayan is $99, Nex Gen $299 — but price is the only dimension on which the comparison is meaningful.
Is Mondae legit?: Mondae is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: Semaglutide $87/mo month-to-month or $75 on 3 months; tirzepatide $126 and $124. Flat at every dose. It is cash-pay and states it does not bill insurance. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. What our record does not establish: which states it serves. Ask for those in writing before you pay.
Is Mondae expensive compared with other GLP-1 telehealth providers?: Mondae publishes a starting figure of $87/mo. Across the 42 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $269 with a median of $179, which puts Mondae below the median, toward the cheaper end. The other 31 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Check availability →

Or compare every GLP-1 provider.